Key indicators: single-crystal X-ray study; T = 120 K; mean (C-C) = 0.003 Å; R factor = 0.053; wR factor = 0.172; data-to-parameter ratio = 16.6.
In the title compound, C 16 H 14 N 2 O 2 , the conformation about the C C bond is E, and the two amide groups are effectively orthogonal [the C-N-N-C torsion angle is 104. 5 (2) ]. In the crystal structure, the amide groups groups associate via N-HÁ Á ÁO hydrogen bonding, forming supramolecular tapes with undulating topology along the c-axis direction.
Related literature
For the biological activity of trans-cinnamic acid derivatives, see: Bezerra et al. (2006) ; Chung & Shin (2007) ; Naz et al. (2006) ; Rastogi et al. (1998) ; Reddy et al. (1995) . For recent studies directed towards developing drugs for the treatment of tuberculosis, see: Carvalho et al. (2008) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ).
Data collection: COLLECT (Hooft, 1998 ); cell refinement: DENZO (Otwinowski & Minor, 1997) and COLLECT; data reduction: DENZO and COLLECT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: DIAMOND (Brandenburg, 2006) ; software used to prepare material for publication: publCIF (Westrip, 2009 ).
The use of the EPSRC X-ray crystallographic service at the University of Southampton, England and the valuable assistance of the staff there is gratefully acknowledged. JLW acknowledges support from CAPES (Brazil). . MDR-TB, defined as resistance to at least isoniazid and rifamycin, two current first-line drugs, has increased morbidity and mortality with an overall increase in health care costs. The first-line treatment has some disadvantages such as important side-effects and weak sterility problems, and must be administered for 6-9 months. When standard treatments fail, second-line TB drugs are used, but these drugs have a far lower efficacy and require even longer administration periods (18-24 months) with higher cost (US $2500-3000 per treatment), higher rates of adverse effects, and low cure rates (around 60%). It is estimated that 4% of all worldwide TB patients are resistant to at least one of the current first-line drugs. TB is responsible for 20% of all deaths in adults, and each year there are about nine million new cases, of which 15% are children, and two million of deaths, of which 450.000 are children. Due to the increase of MDR-TB and AIDS cases worldwide and the lack of new drugs, there is an urgent need for new drugs to fight this disease.
In our continuing research for new potent and anti-malarial agents, we reported on a new class of isonicotinic and benzoic acid N'-(3-phenyl-acryloyl)-hydrazide derivatives as attractive anti-tubercular agents (Carvalho et al., 2008) and now report the structure of N'- [(2E)-3-phenylprop-2-enoyl] benzohydrazide, (I). The choice of trans-cinnamic acid derivatives in this study follows on from earlier reports of their significant biological activities (Bezerra et al., 2006; Chung & Shin, 2007; Naz et al., 2006; Rastogi et al., 1998; Reddy et al., 1995) .
In (I), the conformation about the C7═C8 bond is E, Fig. 1 . There is significant twisting in the molecule, in particular about about the central N1-N2 bond as seen in the value of the C9/N1/N2/C10 torsion angle of 104.5 (2) °. This has the consequence that the amide groups are effectively orthogonal to each other, a feature that facilitates the formation of N-H···O hydrogen bond leading to the formation of undulating supramolecular tapes in the c direction, Fig. 2 C NMR (125 MHz, DMSO-d6) δ: 165.48, 164.45, 140.34, 134.59, 132.45, 131.92, 129.91, 129.07, 127.78, 121.52, 119.45 p.p.m. supplementary materials sup-2 Refinement The C-bound H atoms were geometrically placed (C-H = 0.95 Å) and refined as riding with U iso (H) = 1.2U eq (C). The positions of the amide-N H atoms were refined with U iso (H) = 1.2U eq (N), see Table 1 for distances. Figures   Fig. 1. Molecular structure of (I) showing the atom-labelling scheme and displacement ellipsoids at the 50% probability level. 
